Glenmark Life Sciences Q3 Results

  • BSE: 543322
  • NSE: GLS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
832.65-6.60 (-0.79%)
Volume2.74 K
Updated: Fri 21 Jun, 2024 | 15:28:00
NSE
829.75-9.90 (-1.18%)
Volume43.07 K
Updated: Fri 21 Jun, 2024 | 15:52:38
Today: 826.00
857.00
52-Wk: 556.40
904.20

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Glenmark Life Sciences Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 2,134.021,882.7813.34%2,191.88-2.64%
    Selling/ General/ Admin Expenses Total 168.42161.744.13%151.2311.37%
    Depreciation/ Amortization 61.0361.74-1.15%61.21-0.29%
    Other Operating Expenses Total 60.9438.1959.60%47.9827.03%
    Total Operating Expense 1,687.451,477.4614.21%1,658.271.76%
    Operating Income 446.57405.3210.18%533.61-16.31%
    Net Income Before Taxes 316.31287.0910.18%433.83-27.09%
    Net Income 242.72217.1611.77%323.65-25.01%
    Diluted Normalized EPS 25.1022.4511.80%33.47-25.01%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanGet App